Combination therapy of an IL-15 superagonist complex, ALT-803, and a tumor targeting monoclonal antibody promotes direct antitumor activity and protective vaccinal effect in a syngenic mouse melanoma model. Issue 2 (December 2015) - Chen, Xiaoyue; Liu, Bai; Han, Kaiping; Kong, Lin; Noel, Terra; Jeng, Emily; Alter, Sarah; Rubinstein, Mark; Rhode, Peter; Wong, Hing